139 results
PRE 14A
SYRS
Syros Pharmaceuticals Inc.
12 Apr 24
Preliminary proxy
4:30pm
the relationships that each such non-employee director has with our company and all other facts and circumstances our board of directors deemed relevant … in determining independence, including the beneficial ownership of our capital stock by each non-employee director.
Board Diversity Matrix (as of March 31
S-8
SYRS
Syros Pharmaceuticals Inc.
27 Mar 24
Registration of securities for employees
7:04am
No.)
35 CambridgePark Drive, 4th Floor
Cambridge, Massachusetts
(Address of Principal Executive Offices)
(Zip Code)
2016 Employee Stock Purchase Plan … Statement on Form S-8, relating to the 2016 Employee Stock Purchase Plan (the “2016 ESPP”) of Syros Pharmaceuticals, Inc. (the “Registrant”), is being
S-8
SYRS
Syros Pharmaceuticals Inc.
27 Mar 24
Registration of securities for employees
7:04am
dilution resulting from stock splits, stock dividends or similar transactions.
Consists of 32,035 shares issuable under the 2016 Employee Stock Purchase
S-8
EX-5.1
SYRS
Syros Pharmaceuticals Inc.
27 Mar 24
Registration of securities for employees
7:04am
Cambridge, MA 02140
Re: 2016 Employee Stock Purchase Plan
Ladies and Gentlemen:
We have assisted in the preparation of a Registration Statement … Pharmaceuticals, Inc., a Delaware corporation (the “Company”), issuable under the Company’s 2016 Employee Stock Purchase Plan (the “Plan”).
We have
S-8
EX-23.2
h7mzs 3ab
27 Mar 24
Registration of securities for employees
7:04am
8-K
EX-1.1
5oozi
19 Dec 23
Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants
4:59pm
424B5
ec4vf dxm
19 Dec 23
Prospectus supplement for primary offering
4:53pm
8-K
7cds64y9m2nr 1t
2 Oct 23
Cost Associated with Exit or Disposal Activities
8:49am
8-K
6zt lyt3kk
21 Jul 23
Termination of a Material Definitive Agreement
4:36pm
424B5
0i3f zczdbrccr
1 May 23
Prospectus supplement for primary offering
4:06pm